Product Name | MF | CAS | Details |
---|
N-(4-Hydroxyphenyl)acetamide sulfate-d3 sodium | C8H10NNaO5S | 2733160-80-8 | Details |
H-FLSLDYIPQR-OH | Details |
Parvovirus B19 IgG Positive Human Plasma | Details |
3-Fluoro-6-methoxypyridine-2-carbaldehyde | C7H6FNO2 | 1227584-16-8 | Details |
RPS4X antibody | Details |
(4-Bromobutyl)dimethylamine hydrobromide | C6H15Br2N | 17375-58-5 | Details |
2,2,2-Trifluoroethyl N-(5-chloro-2-methoxyphenyl)carbamate | C10H9ClF3NO3 | 1087788-91-7 | Details |
2,5-Dimethylfuran-3-sulfonamide | C6H9NO3S | 858248-39-2 | Details |
Bay 11-7085 | C13H15NO2S | 196309-76-9 | Details |
BRD 0705 | C20H23N3O | 1597440-03-3 | Details |
1-ethyl 4-methyl benzene-1,4-dicarboxylate | C11H12O4 | 22163-52-6 | Details |
TERT antibody | Details |
CD37 antibody | Details |
Methyl 2-(2H-1,2,3-triazol-2-yl)acetate | C5H7N3O2 | 868833-93-6 | Details |
NFKBIA antibody | Details |
Nidanilimab | 2171061-85-9 | Details |
2,2-Difluoro-2-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)acetic acid | C8H7F2NO3 | 1860877-05-9 | Details |
2-hydroxybutanoic acid | C4H8O3 | 600-15-7 | Details |
Lanatoside C | C49H76O20 | 17575-22-3 | Details |
Ethyl 2-amino-6-bromo--cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetate | C17H17BrN2O5 | 927635-64-1 | Details |
H-SLYVQASGRVTVSTRR-OH | Details |
A1 N-Glycan | C73H121N5O54 | 145211-79-6 | Details |
2-Methoxyhydroquinone | C7H8O3 | 824-46-4 | Details |
Bazedoxifene 4’-β-D-glucuronide | C36H42N2O9 | 328933-64-8 | Details |
Sodium trifluoromethanesulfonate | CF3NaO3S | 2926-30-9 | Details |
1-(2-Fluoro-ethyl)-4-iodo-1H-pyrazole-3-carboxylic acid methyl ester | C7H8FIN2O2 | 1429418-23-4 | Details |
2-{[2-(3-Fluorophenyl)-2-hydroxyethyl]amino}-2-methylpropan-1-ol | C12H18FNO2 | 1179948-01-6 | Details |
BCL2 antibody | Details |
H-YEASILTHDSSIR-OH | Details |
DNA damage-binding protein 2 (DDB2)-[Cys(AF647)]-amide | Details |
YM-298198 hydrochloride | C18H23ClN4OS | 1216398-09-2 | Details |
CDK4/6-IN-2 | C27H32F2N8 | 1800506-48-2 | Details |
3-(4-Fluorophenyl)-1,2,4-thiadiazol-5-amine | C8H6FN3S | 874356-96-4 | Details |
3-(4-Methyl-1,3-thiazol-2-yl)thiomorpholine dihydrochloride | C8H12N2S2.2ClH | 2248347-49-9 | Details |
6-Formylpicolinonitrile | C7H4N2O | 85148-95-4 | Details |
7-Aminopyrazolo[1,5-a]pyrimidine-3-carboxylic acid | C7H6N4O2 | 1781791-76-1 | Details |
KN-92 hydrochloride | C24H26Cl2N2O3S | 1431698-47-3 | Details |
Sphingosine-d7 | C18H30D7NO2 | 1246304-34-6 | Details |
3-Methyl-3,4-dihydro-1H-quinoxalin-2-one | C9H10N2O | 34070-68-3 | Details |
Hexahydrophenyl cinacalcet hydrochloride | C22H28F3N | 1271930-12-1 | Details |
6-Bromo-3-fluoro-1H-indazole | C7H4BrFN2 | 1463055-91-5 | Details |
1,2-Dimethyl 1-cyanocyclobutane-1,2-dicarboxylate | C9H11NO4 | 14132-45-7 | Details |
3-Ethyl-3-methyloxan-4-one | C8H14O2 | 2229530-84-9 | Details |
Chloromonilinic acid B | C16H13ClO7 | 121927-79-5 | Details |
Cyclopentyl bromide | C5H9Br | 137-43-9 | Details |
2-Cyclobutoxy-4,6-dimethylpyridine-3-carbonitrile | C12H14N2O | 1247157-16-9 | Details |
NF2 antibody | Details |
RUVBL1 antibody | Details |
1,4-Diazepan-2-one | C5H10N2O | 99822-50-1 | Details |
LGICZ1 Blocking Peptide | Details |
1-Amino-2,3-dihydro-1H-indene-4,6-dicarboxylic acid hydrochloride | C11H11NO4.ClH | 2287343-97-7 | Details |
3,3-Dimethyl-1-(thian-4-yl)urea | 1596902-81-6 | Details |
3-Methylamino-1,2-propanediol | C4H11NO2 | 40137-22-2 | Details |
2-Isocyanato-1-benzothiophene | C9H5NOS | 124808-79-3 | Details |
5-(Pyrrolidin-1-yl)pentanoic acid hydrochloride | C9H18ClNO2 | 133095-33-7 | Details |
3-(2,3,5-Tri-O-benzyl-1-b-D-ribofuranosyl)benzamide | C33H33NO5 | 138385-42-9 | Details |
{6-Methyl-6-azaspiro[3.5]nonan-7-yl}methanamine dihydrochloride | C10H21ClN2 | 2193059-49-1 | Details |
2-Methyl-1-{1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-1H-imidazole | C10H10N6 | 1328260-83-8 | Details |
2-[6-Methyl-4-oxo-2-(pyrimidin-2-yl)-1,4-dihydropyrimidin-5-yl]acetic acid | C11H10N4O3 | 1240529-49-0 | Details |
Sodium 1-hydroxy-2-methylpropane-1-sulfonate | C4H11NaO4S | 13023-74-0 | Details |
5-Bromo-4-chloro-1H-benzoimidazole | C7H4BrClN2 | 1008361-81-6 | Details |
H-KVEKIGEGTYGVVYK-NH2 | Details |
Ethyl 5-{[(tert-butoxy)carbonyl]amino}pent-3-ynoate | C12H19NO4 | 1185884-99-4 | Details |
3,5-Difluoroadamantan-1-amine | C10H15F2N | 214557-82-1 | Details |
2,2,2-Trifluoroethyl N-[3-(pyrrolidin-1-yl)propyl]carbamate | C10H17F3N2O2 | 1306603-23-5 | Details |
Troponin I Type 1 Blocking Peptide | Details |
Cusatuzumab | 1864871-20-4 | Details |
9-Demethyl FR-901235 | C17H14O7 | 1029520-85-1 | Details |
3-Aminooxetane-3-carboxylic acid, N-FMOC protected | C19H17NO5 | 1380327-56-9 | Details |
BFSP1 Blocking Peptide | Details |
2,4-Diphenylbutanoic acid | C16H16O2 | 2901-34-0 | Details |
Fmoc-Gly-Gly-Phe-OH | C28H27N3O6 | 160036-44-2 | Details |
(1R,4R)-4-Butoxycyclohexan-1-amine hydrochloride | 913747-70-3 | Details |
IgG1 kappa Isotype Control Fc fusion protein (FITC) | Details |
Senecionine N-oxide | C18H25NO6 | 13268-67-2 | Details |
2-Fluoro-2-methyl-1-propanol | C4H9FO | 3109-99-7 | Details |
5-Cyanopyrazolo[1,5-a]pyridine-3-carboxylic acid | C9H5N3O2 | 1352900-89-0 | Details |
4,5-Difluoro-2-hydroxybenzoic acid | C7H4F2O3 | 205533-31-9 | Details |
2-Hydroxy-1-(4-methylphenyl)ethanone | C9H10O2 | 4079-54-3 | Details |
3-(1H-1,2,3,4-Tetrazol-1-yl)aniline hydrochloride | C7H7N5.ClH | 436100-10-6 | Details |
6-(1-Methyl-1H-pyrazol-4-yl)-2,3-dihydropyridazin-3-one | C8H8N4O | 1100598-49-9 | Details |
tert-butyl 3-amino-3-(trifluoromethyl)pyrrolidine-1-carboxylate | C10H17F3N2O2 | 1260795-79-6 | Details |
(4-tert-Butyl-benzoylamino)-acetic acid | C13H17NO3 | 87015-91-6 | Details |
5-Nitro-6-(1,3-thiazol-5-yl)piperidin-2-one | C8H9N3O3S | 1803571-10-9 | Details |
[2-(Aminomethyl)-3-methylbutyl]benzene hydrochloride | C12H20ClN | 1797555-17-9 | Details |
NAGS antibody | Details |
Ethyl 6-bromo-[1,2,4]triazolo[1,5-a]pyridine-2-carboxylate | C9H8BrN3O2 | 1427376-40-6 | Details |
2-((4-chlorophenyl)sulfonyl)-3-((2-fluoro-5-(trifluoromethyl)phenyl)amino)prop-2-enenitrile | C16H9ClF4N2O2S | 1025661-26-0 | Details |
6-Chloro-3-methyl-1H-indole-2-carboxylic acid | C10H8ClNO2 | 441801-03-2 | Details |
(3-Ethyl-5-methyl-1,2-oxazol-4-yl)methanamine | C7H12N2O | 1503307-32-1 | Details |
Potassium (dimethyl-1,2,4-triazin-3-yl)sulfanide | C5H8KN3S | 2228155-76-6 | Details |
4,6-Dichloro-2-(ethoxymethyl)pyrimidine | C7H8Cl2N2O | 3122-82-5 | Details |
α-[[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]methyl]-1,3-benzodioxole-5-propanoic acid | C26H23NO6 | 683217-91-6 | Details |
1-Chloro-6-azaspiro[2.5]octane-1-carboxylic acid hydrochloride | 2375270-82-7 | Details |
MRGX4 antibody | Details |
Trpv6 antibody | Details |
H-CQNYVMASFYK-OH | Details |
L-amino-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate lithium | C6H6LiN5O2 | 2241140-74-7 | Details |
Acid Brown 160 | 61724-12-7 | Details |
Ethyl N-ethyl-beta-alaninate | C7H15NO2 | 23651-62-9 | Details |
Product Total: Product Page: | ||||
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |